AtaiBeckley (ATAI) Other Non-Current Assets (2020 - 2026)
AtaiBeckley (ATAI) recorded quarterly Other Non-Current Assets of $1.1 million in Q1 2026, down 1.62% quarter-over-quarter from $1.1 million in Q4 2025.
AtaiBeckley (ATAI) Other Non-Current Assets (2020 - 2026) Analysis & Trends
AtaiBeckley's Other Non-Current Assets history runs 3 years deep, the most recent figure standing at $1.1 million for Q1 2026.
- In Q1 2026, Other Non-Current Assets changed N/A year-over-year to $1.1 million; the TTM figure through Mar 2026 stood at $1.1 million (changed N/A YoY), while the FY2025 annual figure was $1.1 million, up 30.59% from the prior year.
- Other Non-Current Assets was $1.1 million for Q1 2026 at AtaiBeckley, down from $1.1 million in the prior quarter.
- In the past five years, Other Non-Current Assets ranged from a high of $10.0 million in Q1 2025 to a low of $382000.0 in Q3 2025.
- The 5-year median for Other Non-Current Assets is $2.8 million (2023), against an average of $3.7 million.
- Biggest YoY gain for Other Non-Current Assets was 30.59% in 2025; the steepest drop was 30.59% in 2025.
- A 3-year view of Other Non-Current Assets shows it stood at $850000.0 in 2024, then jumped by 30.59% to $1.1 million in 2025, then slipped by 1.62% to $1.1 million in 2026.
- The last three Other Non-Current Assets figures came in at $1.1 million (Q1 2026), $1.1 million (Q4 2025), and $850000.0 (Q4 2024), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | - |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | 60,000.00 |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | - |
| 10 | AtaiBeckley | 1.45 Bn | 1.45 Bn | - | 1.09 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.09 Mn |
| Dec 31, 2025 | 1.11 Mn |
| Sep 30, 2025 | 382,000.00 |
| Jun 30, 2025 | 389,000.00 |
| Mar 31, 2025 | 10.00 Mn |
| Dec 31, 2024 | 850,000.00 |
| Dec 31, 2024 | 850,000.00 |
| Sep 30, 2024 | 2.43 Mn |
| Jun 30, 2024 | 2.43 Mn |
| Mar 31, 2024 | 2.57 Mn |
| Dec 31, 2023 | 948,000.00 |
| Sep 30, 2023 | 3.11 Mn |
| Jun 30, 2023 | 3.27 Mn |
| Mar 31, 2023 | 3.18 Mn |
| Dec 31, 2022 | 3.13 Mn |
| Sep 30, 2022 | 8.74 Mn |
| Jun 30, 2022 | 7.59 Mn |
| Mar 31, 2022 | 7.50 Mn |
| Dec 31, 2021 | 7.34 Mn |
| Sep 30, 2021 | 1.26 Mn |